NO954390L - Fremgangsmåte for bekjempelse av acyklovir-resistente Herpes simplex virus-infeksjoner - Google Patents

Fremgangsmåte for bekjempelse av acyklovir-resistente Herpes simplex virus-infeksjoner

Info

Publication number
NO954390L
NO954390L NO954390A NO954390A NO954390L NO 954390 L NO954390 L NO 954390L NO 954390 A NO954390 A NO 954390A NO 954390 A NO954390 A NO 954390A NO 954390 L NO954390 L NO 954390L
Authority
NO
Norway
Prior art keywords
alkyl
amino acid
acyclovir
peptide derivative
combating
Prior art date
Application number
NO954390A
Other languages
English (en)
Norwegian (no)
Other versions
NO954390D0 (no
Inventor
James Gus Chafouleas
Robert Deziel
Original Assignee
Bio Mega Boehringer Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Mega Boehringer Ingelheim filed Critical Bio Mega Boehringer Ingelheim
Publication of NO954390D0 publication Critical patent/NO954390D0/no
Publication of NO954390L publication Critical patent/NO954390L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO954390A 1993-05-03 1995-11-02 Fremgangsmåte for bekjempelse av acyklovir-resistente Herpes simplex virus-infeksjoner NO954390L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002095408A CA2095408A1 (en) 1993-05-03 1993-05-03 Method of combating acyclovir-resistant herpes simplex viral infections
PCT/CA1994/000242 WO1994025046A1 (en) 1993-05-03 1994-04-29 Method of combating acyclovir-resistant herpes simplex viral infections

Publications (2)

Publication Number Publication Date
NO954390D0 NO954390D0 (no) 1995-11-02
NO954390L true NO954390L (no) 1996-01-02

Family

ID=4151571

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954390A NO954390L (no) 1993-05-03 1995-11-02 Fremgangsmåte for bekjempelse av acyklovir-resistente Herpes simplex virus-infeksjoner

Country Status (13)

Country Link
EP (1) EP0767671A1 (ko)
JP (1) JPH08509476A (ko)
KR (1) KR960701651A (ko)
CN (1) CN1126438A (ko)
AU (1) AU683465B2 (ko)
BR (1) BR9406575A (ko)
CA (1) CA2095408A1 (ko)
CZ (1) CZ287795A3 (ko)
HU (1) HUT73779A (ko)
NO (1) NO954390L (ko)
SG (1) SG48806A1 (ko)
SK (1) SK132695A3 (ko)
WO (1) WO1994025046A1 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817638A (en) * 1988-07-07 1998-10-06 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US6252060B1 (en) 1988-07-07 2001-06-26 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US6599887B2 (en) 1988-07-07 2003-07-29 Chimerix, Inc. Methods of treating viral infections using antiviral liponucleotides
CA2139169C (en) * 1994-12-28 2001-05-01 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Antiherpes peptidomimetic compounds
CN109627243B (zh) * 2019-01-09 2021-06-29 广西壮族自治区水产科学研究院 一种喷昔洛韦-铜配合物、合成方法及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2033448C (en) * 1990-12-31 1996-11-26 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Antiherpes compositions and method of use
SG42995A1 (en) * 1992-03-12 1997-10-17 Bio Mega Boehringer Ingelheim Isosteric antiherpes peptide derivatives

Also Published As

Publication number Publication date
CZ287795A3 (en) 1996-06-12
HUT73779A (en) 1996-09-30
CA2095408A1 (en) 1994-11-04
SG48806A1 (en) 1998-05-18
CN1126438A (zh) 1996-07-10
NO954390D0 (no) 1995-11-02
KR960701651A (ko) 1996-03-28
AU6642394A (en) 1994-11-21
WO1994025046A1 (en) 1994-11-10
SK132695A3 (en) 1996-10-02
AU683465B2 (en) 1997-11-13
EP0767671A1 (en) 1997-04-16
BR9406575A (pt) 1996-03-19
HU9503135D0 (en) 1996-01-29
JPH08509476A (ja) 1996-10-08

Similar Documents

Publication Publication Date Title
NO960713L (no) Substituerte azaindolylidenforbindelser og fremgangsmåte for deres fremstilling
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
NO954390L (no) Fremgangsmåte for bekjempelse av acyklovir-resistente Herpes simplex virus-infeksjoner
DE60036862D1 (de) Synergistische hemmung von viralreplikation durch langkettigen kohlenwasserstoffe und nucleosid-analoge
ATE169931T1 (de) Isosterische peptidderivate gegen herpes
DK629889D0 (da) Aminosyrederivater, deres fremstilling og anvendelse som laegemidler
AR003456A1 (es) Un compuesto analogo de distamicina y sus sales, procedimiento para su preparacion, composicion farmaceutica que lo contiene y usos del mismo.
ZA93996B (en) Pyrrolidine compounds, processes for preparing them and pharmaceutical compositions containing them.
NO921908L (no) Aminosyreazetidinylsubstituerte pyridonderivater, deres fremstilling og anvendelse som medikamenter
ES2152269T3 (es) Inhibidores de ribonucleotido-reductasa de herpesvirus.
RU93004779A (ru) Производные пептидов и их терапевтически приемлемые соли, способ их получения, фармацевтическая и косметическая композиция, способ лечения заражений вирусом герпеса
FI944076A (fi) Menetelmä terapeuttisesti käytt¦kelpoisten N-(3-hydroksi-4-piperidinyyli)(dihydrobentsofuraani-, dihydro-2H-bentsopyraani- tai dihydrobentsodioksiini)karboksamidijohdannaisten valmistamiseksi ja välituote
NO921406L (no) Gem-difosfonsyrer, fremgangsmaate ved deres fremstilling og farmasoeytiske sammensetninger som inneholder dem